Sawai Y - Search Results

1

Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effects.

Uzawa K, Kasamatsu A, Saito T, Kita A, Sawai Y, Toeda Y, Koike K, Nakashima D, Endo Y, Shiiba M, Takiguchi Y, Tanzawa H. Uzawa K, et al. Among authors: sawai y. Exp Cell Res. 2019 Mar 15;376(2):210-220. doi: 10.1016/j.yexcr.2019.01.016. Epub 2019 Jan 25. Exp Cell Res. 2019. PMID: 30690028

2

Critical role of deoxynucleotidyl transferase terminal interacting protein 1 in oral cancer.

Sawai Y, Kasamatsu A, Nakashima D, Fushimi K, Kasama H, Iyoda M, Kouzu Y, Shiiba M, Tanzawa H, Uzawa K. Sawai Y, et al. Lab Invest. 2018 Aug;98(8):980-988. doi: 10.1038/s41374-018-0070-3. Epub 2018 May 31. Lab Invest. 2018. PMID: 29855544 Free article.

3

Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma.

Uzawa K, Amelio AL, Kasamatsu A, Saito T, Kita A, Fukamachi M, Sawai Y, Toeda Y, Eizuka K, Hayashi F, Kato-Kase I, Sunohara M, Iyoda M, Koike K, Nakashima D, Ogawara K, Endo-Sakamoto Y, Shiiba M, Takiguchi Y, Yamauchi M, Tanzawa H. Uzawa K, et al. Among authors: sawai y. Sci Rep. 2019 Aug 21;9(1):12179. doi: 10.1038/s41598-019-48717-w. Sci Rep. 2019. PMID: 31434965 Free PMC article.

4

Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.

Sawai Y, Yamaoka K, Nakagawa T. Sawai Y, et al. Pharm Res. 1998 Jul;15(7):1007-11. doi: 10.1023/a:1011917824836. Pharm Res. 1998. PMID: 9688052

5

Moment analysis of intestinal first-pass metabolism by portal-systemic concentration difference in single conscious rat using 5'-deoxy-5-fluorouridine and 5-fluorouracil as model drug system.

Sawai Y, Yamaoka K, Takemura A, Nakagawa T. Sawai Y, et al. J Pharm Sci. 1997 Nov;86(11):1269-72. doi: 10.1021/js970103o. J Pharm Sci. 1997. PMID: 9383738

6

Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.

Sawai Y, Yamaoka K, Ito T, Nakagawa T. Sawai Y, et al. Biol Pharm Bull. 1997 Dec;20(12):1313-6. doi: 10.1248/bpb.20.1313. Biol Pharm Bull. 1997. PMID: 9448112

7

Introduction of recirculatory analysis into portal and systemic concentration difference method.

Ueda S, Yamaoka K, Sawai Y, Nakagawa T. Ueda S, et al. Among authors: sawai y. Biol Pharm Bull. 2001 Nov;24(11):1298-304. doi: 10.1248/bpb.24.1298. Biol Pharm Bull. 2001. PMID: 11725968 Free article.

8

Asynchronous climate changes in the North Atlantic and Japan during the last termination.

Nakagawa T, Kitagawa H, Yasuda Y, Tarasov PE, Nishida K, Gotanda K, Sawai Y; Yangtze River Civilization Program Members. Nakagawa T, et al. Among authors: sawai y. Science. 2003 Jan 31;299(5607):688-91. doi: 10.1126/science.1078235. Science. 2003. PMID: 12560547

9

Pharmacokinetics of enoximone after various intravenous administrations to healthy volunteers.

Morita S, Sawai Y, Heeg JF, Koike Y. Morita S, et al. Among authors: sawai y. J Pharm Sci. 1995 Feb;84(2):152-7. doi: 10.1002/jps.2600840206. J Pharm Sci. 1995. PMID: 7738792 Clinical Trial.

10

Simultaneous determination of deflazacort metabolites II and III, cortisol, cortisone, prednisolone and prednisone in human serum by reversed-phase high-performance liquid chromatography.

Hirata H, Kasama T, Sawai Y, Fike RR. Hirata H, et al. Among authors: sawai y. J Chromatogr B Biomed Appl. 1994 Aug 5;658(1):55-61. doi: 10.1016/0378-4347(94)00193-6. J Chromatogr B Biomed Appl. 1994. PMID: 7952132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page